5Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone(1-34) on fractures and bone mineral density in postmenopausa/ women with osteoporosis. N Engl J Med, 2001, 344: 1434- 1441.
6Colpan L, Gur A, Cerik R, et al. The effect of caleitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis. Maturitas, 2005,51 : 246-253.
7Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med, 2000, 343 : 604-610.
8Body JJ, Gaich GA, Scheele WH, et al. A randomized double-blind trial to compare the efficacy of teriparatide [ recombinant human parathyroid hormone(1-34) ]with alendronate in postmenopansal women with osteoporosis. J Clin Endocrinol Metab, 2002,87:4528-4535.
9Pettway GJ, Meganck JA, Koh A J, et al. Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. Bone, 2008, 42: 806-818.
10Hwang JS, Tu ST, Yang TS, et al. Teriparatide vs calcitonin in the treatment of Asian postmenopausal women with established osteoporosis. Osteoporos Int, 2006, 17: 373-378.
